By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


AstraZeneca PLC 

15 Stanhope Gate

London  England  W1K 1LN  United Kingdom
Phone: 44-20-7304-5000 Fax: 44-20-7304-5151


Company News
AstraZeneca PLC (AZN), GlaxoSmithKline (GSK), Novartis AG (NVS) and Roche (RHHBY) React to Brexit and Its Possible Impact on Biotech 6/24/2016 6:24:04 AM
Teva (TEVA) Settles Patent Litigation With AstraZeneca PLC (AZN) Allowing Teva To Commercialize Its Generic Version Of Byetta┬« (Exenatide Injection) In The United States 6/23/2016 8:16:40 AM
AstraZeneca PLC (AZN) Takes a $80 Million Hit as the CDC Says Flu Vaccine Flumist Does Not Work 6/23/2016 5:50:47 AM
Hutchison China MediTech (Chi-Med) Earns $10 Million Milestone From AstraZeneca PLC (AZN) In Lung Cancer Trial 6/21/2016 2:58:31 PM
AstraZeneca PLC (AZN) Introduces AZhelps, An Innovative Savings And Support Program To Help Patients With Their Medicines 6/14/2016 8:25:23 AM
AstraZeneca PLC (AZN) Presents New Data From Multiple Studies On The Effect Of BYDUREON On Glucose Fluctuations In Patients With Type 2 Diabetes 6/13/2016 10:59:29 AM
AstraZeneca PLC (AZN) Presents Findings From Two Pooled Analyses At The 76th Scientific Sessions Of The American Diabetes Association Evaluating Dapagliflozin In Type 2 Diabetes Patients With Renal Impairment And In Combination With Potassium-Sparing Agents 6/13/2016 10:56:58 AM
Aspen Pharmacare Bags Anaesthetics Portfolio from AstraZeneca PLC (AZN) in $770 Million Deal 6/9/2016 5:44:14 AM
AstraZeneca PLC (AZN) To Present Anifrolumab Lupus Data At Annual European Congress Of Rheumatology (EULAR 2016) 6/8/2016 2:35:21 PM
AstraZeneca PLC (AZN) To Highlight Scientific Advancements Across Its Diabetes Portfolio At The American Diabetes Association 76th Scientific Sessions 6/8/2016 8:36:40 AM